MENS

Jyong Biotech Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth 0/10
  • Momentum 0/10
Jyong Biotech sales and earnings growth
MENS Growth
Low
  • Revenue Y/Y 0.00%
  • EPS Y/Y 0.00%
  • FCF Y/Y -92.46%
Jyong Biotech gross and profit margin trends
MENS Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC -31.40%
Jyong Biotech net debt vs free cash flow
MENS Risk
Great
  • Debt / Equity -0.5
  • Debt / FCF 4.2
  • Interest coverage -3.7

Jyong Biotech stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗